The objective of this order is to purchase service support from the Contractor who shall utilize
SEM/EDS, XPS, and cryo-SEM to fulfil the Government’s needs of characterizing and analyzing
nanoparticle-coated medical device materials, bacterial biofilms of BSL-2 microorganisms formed on
metal coupons and mammalian tissue cells. The outcomes of this work will provide the necessary
quantitative and qualitative data for evaluating the stability and efficacy of NPs containing materials.
Instructions to Qutors
a. This is a combined/synopsis solicitation issued under FAR Part 12 and 13.5 procedures. This
is full and open competition procurement. The NAICS code is 544713 – Nanotechnology
Research and Development Laboratories or Services.
b. Quoters shall certify their quotes to be valid for at least 30 days.
c. Quoters shall submit a quote for all requirements listed in this RFQ. Partial quotes will not be
considered. Incomplete pricing or pricing with omissions may not be considered for award.
d. Quoters shall submit all assumptions in their quotation.
e. Quoters are advised that additional terms and conditions submitted with their quotation that is
in conflict of the terms and conditions of this solicitation may be deems as technically
unacceptable and may not be considered for award. All additional terms and conditions must
be submitted with its quotation.
f. Quoters providing quotations must clearly state the overall cost to the Government.
g. Quoters shall ensure that their initial submission represents their best pricing and that all
information is provided to determine technical acceptability. The Government will not
research items to determine compatibility; all information regarding compatibility must be
contained within the quotation.
h. Quotes shall confirm in writing that all the requirements of this RFQ, especially those listed
on Section 3 and 4, will be met.
i. Please submit questions to Min Jie (Terry) Zeng via email at minjie.zeng@fda.hhs.gov by
September 10, 2021, 4PM Eastern Time.
j. Please submit quotes to Min Jie (Terry) Zeng via email at minjie.zeng@fda.hhs.gov by
September 15, 2021, 4PM Eastern Time.
